<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28387837</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>02</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2049-632X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>75</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Pathogens and disease</Title>
          <ISOAbbreviation>Pathog Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genomic sequencing of Neisseria gonorrhoeae to respond to the urgent threat of antimicrobial-resistant gonorrhea.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femspd/ftx041</ELocationID>
        <Abstract>
          <AbstractText>The development of resistance of Neisseria gonorrhoeae to available first-line antibiotics, including penicillins, tetracyclines, fluoroquinolones and cephalosporins, has led to the circulation of multidrug-resistant gonorrhea at a global scale. Advancements in high-throughput whole-genome sequencing (WGS) provide useful tools that can be used to enhance gonococcal detection, treatment and management capabilities, which will ultimately aid in the control of antimicrobial resistant gonorrhea worldwide. In this minireview, we discuss the application of WGS of N. gonorrhoeae to strain typing, phylogenomic, molecular surveillance and transmission studies. We also examine the application of WGS analyses to the public health sector as well as the potential usage of WGS-based transcriptomic and epigenetic methods to identify novel gonococcal resistance mechanisms.</AbstractText>
          <CopyrightInformation>Published by Oxford University Press on behalf of FEMS 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abrams</LastName>
            <ForeName>A Jeanine</ForeName>
            <Initials>AJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trees</LastName>
            <ForeName>David L</ForeName>
            <Initials>DL</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>CC999999</GrantID>
            <Acronym>ImCDC</Acronym>
            <Agency>Intramural CDC HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pathog Dis</MedlineTA>
        <NlmUniqueID>101595366</NlmUniqueID>
        <ISSNLinking>2049-632X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="Y">Drug Resistance, Multiple, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006069" MajorTopicYN="N">Gonorrhea</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="Y">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="Y">gonorrhea</Keyword>
        <Keyword MajorTopicYN="Y">whole-genome sequencing</Keyword>
      </KeywordList>
      <CoiStatement><b><i>Conflict of interest</i></b>. None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28387837</ArticleId>
        <ArticleId IdType="mid">NIHMS1062768</ArticleId>
        <ArticleId IdType="pmc">PMC6956991</ArticleId>
        <ArticleId IdType="doi">10.1093/femspd/ftx041</ArticleId>
        <ArticleId IdType="pii">3106325</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adam M, Murali B, Glenn NO
et al.
Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol Biol
2008;8:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2262874</ArticleId>
            <ArticleId IdType="pubmed">18282299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ali S, Sewunet T, Sahlemariam Z
et al.
Neisseria gonorrhoeae among suspects of sexually transmitted infection in Gam-bella hospital, Ethiopia: risk factors and drug resistance. BMC Res Notes
2016;9:439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5020457</ArticleId>
            <ArticleId IdType="pubmed">27619365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol
1999;2:489–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10508723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neisseria gonorrhoeae. Lancet
1976;ii:657–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">60519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Sexual Health Alliance. Gonorrhoea - Australian STI Management Guidelines. Australian Government Department of Health, 2016, http://www.sti.guidelines.org.au/sexually-transmissible-infections/gonorrhoea (date last accessed,
20 April 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Baquero F. Epigenetics, epistasis and epidemics. Evol Med Public Health
2013;1:86–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3868410</ArticleId>
            <ArticleId IdType="pubmed">24481189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baquero F, Lanza VF, Cantón R
et al.
Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evol Appl
2015;8:223–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4380917</ArticleId>
            <ArticleId IdType="pubmed">25861381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett JS, Jolley KA, Sparling PF
et al.
Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Bio
2007;5:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2031879</ArticleId>
            <ArticleId IdType="pubmed">17825091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS
2013;24:85–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24400344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biswas GD, Sox T, Blackman E
et al.
Factors affecting genetic transformation of Neisseria gonorrhoeae. J Bacteriol
1977;129:983–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC235038</ArticleId>
            <ArticleId IdType="pubmed">14116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brazier JS. Clostridium difficile: from obscurity to superbug. Brit J Biomed Sci
2008;65:39–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18476496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadesús J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol Mol Biol R
2006;70:830–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1594586</ArticleId>
            <ArticleId IdType="pubmed">16959970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2014. Atlanta: US Department of Health and Human Services, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2015. Atlanta: US Department of Health and Human Services, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen SC, Yin YP, Dai XQ
et al.
First nationwide study Regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China. J Antimicrob Chemoth
2016; 71:92–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26472770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem
2014;60:724–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24227285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole MJ, Spiteri G, Chisholm SA
et al.
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. Eurosurveil-lance
2014;19:20955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25411689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa-Lourenço AP, Abrams JA, dos Santos KT
et al.
Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil. Int J Antimicrob Ag
2017;49:515–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6934037</ArticleId>
            <ArticleId IdType="pubmed">28232214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cousin SL Jr, Whittington WL, Roberts MC. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemoth
2003;51:131–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12493797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis BM, Chao MC, Waldor MK. Entering the era of bacterial epigenomics with single molecule real time DNA sequencing. Curr Opin Microbiol
2013;16:192–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3646917</ArticleId>
            <ArticleId IdType="pubmed">23434113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day T, Gandon S. The evolutionary epidemiology of multilocus drug resistance. Evolution
2012;66:1582–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22519792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Curraize C, Kumanski S, Micaëlo M
et al.
Ceftriaxone-resistant Neisseria gonorrhoeae isolates (2010 to 2014) in France characterized by using whole-genome sequencing. Antimicrob Agents Ch
2016;60:6962–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5075118</ArticleId>
            <ArticleId IdType="pubmed">27600036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Silva D, Peters J, Cole K
et al.
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study. Lancet
2016;16:1295–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5086424</ArticleId>
            <ArticleId IdType="pubmed">27427203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demczuk W, Lynch T, Martin I
et al.
Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol
2015;53:191–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4290921</ArticleId>
            <ArticleId IdType="pubmed">25378573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demczuk W, Martin I, Peterson S
et al.
Genomic epidemiology and molecular resistance mechanisms of azithromycin resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol
2016;54:1304–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4844716</ArticleId>
            <ArticleId IdType="pubmed">26935729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Didelot X, Dordel J, Whittles LK
et al.
Genomic analysis and comparison of two gonorrhea outbreaks. mBio
2016;7:e00525–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4937209</ArticleId>
            <ArticleId IdType="pubmed">27353752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis
2007;45:88–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17554708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowson CG, Jephcott AE, Gough KR
et al.
Penicillin-binding protein 2 genes of non-β-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol
1989;3:35–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2497297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunne WM Jr, Westblade LF, Ford B. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol
2012;31:1719–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22678348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezewudo MN, Joseph SJ, Castillo-Ramirez S
et al.
Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance. Peer J
2015;3:e806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4358642</ArticleId>
            <ArticleId IdType="pubmed">25780762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fifer H, Natarajan U, Jones L
et al.
Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med
2016;374:2504–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27332921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flusberg BA, Webster DR, Lee JH
et al.
Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Meth
2010;7:461–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2879396</ArticleId>
            <ArticleId IdType="pubmed">20453866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galarza PG, Abad R, Canigia LF
et al.
New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob Agents Ch
2010;54:1652–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2849369</ArticleId>
            <ArticleId IdType="pubmed">20123998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Ch
2000;44:1365–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC89873</ArticleId>
            <ArticleId IdType="pubmed">10770780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grad YH, Kirkcaldy RD, Trees D
et al.
Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet
2014;14:220–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4030102</ArticleId>
            <ArticleId IdType="pubmed">24462211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grad YH, Harris SR, Kirkcaldy RD
et al.
Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000–2013. J Infect Dis
2016;214:1579–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5091375</ArticleId>
            <ArticleId IdType="pubmed">27638945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham RMA, Doyle CJ, Jennison AV. Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing. Sex Transm Infect
2017;93:65–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26968786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goire N, Lahra MM, Chen M
et al.
Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol
2014;12:223–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24509781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golparian D, Shafer WM, Ohnishi M
et al.
Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Ch
2014;58:3556–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068427</ArticleId>
            <ArticleId IdType="pubmed">24733458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamze M, Osman M, Achkar M
et al.
Alarming increase in prevalence of Neisseria gonorrhoeae infections associated with a high level of antibiotic resistance in Tripoli, Lebanon . Int J Antimicrob Ag
2016;48:576–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27667565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hananta IPY, van Dam AP, Bruisten SM
et al.
Gonorrhea in Indonesia: high prevalence of asymptomatic urogenital gonorrhea but no circulating extended spectrum cephalosporins-resistant Neisseria gonorrhoeae strains in Jakarta, Yogyakarta, and Denpasar, Indonesia. Sex Transm Dis
2016;43:608–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27626188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoenen T, Groseth A, Rosenke K
et al.
Nanopore sequencing as a rapidly deployable Ebola outbreak tool. Emerg Infect Dis
2016;22:331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4734547</ArticleId>
            <ArticleId IdType="pubmed">26812583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu M, Nandi S, Davies C
et al.
High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Ch
2005;49:4327–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1251527</ArticleId>
            <ArticleId IdType="pubmed">16189114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ippolito G, Leone S, Lauria FN
et al.
Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infect Dis
2010; 14:S7–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20851011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobsson S, Golparian D, Cole M
et al.
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC &gt; 2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. J Antimicrob Chemoth
2016;71:3109–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27432597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson SR, Grad Y, Abrams AJ
et al.
Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance. Int J Antimicrob Ag
2016;49:252–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6927039</ArticleId>
            <ArticleId IdType="pubmed">28038960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khachatourians GG. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria. Can Med Assoc J
1998;159:1129–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1229782</ArticleId>
            <ArticleId IdType="pubmed">9835883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubanov A, Vorobyev D, Chestkov A
et al.
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015). BMC Infect Dis
2016;16:389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4977856</ArticleId>
            <ArticleId IdType="pubmed">27506605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwong JC, McCallum N, Sintchenko V
et al.
Whole genome sequencing in clinical and public health microbiology. Pathology
2015;47:199–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4389090</ArticleId>
            <ArticleId IdType="pubmed">25730631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee GC, Long S, Musser JM
et al.
Comparative whole genome sequencing of community-associated methicillin-resistant Staphylococcus aureus sequence type 8 from primary care clinics in a Texas community. Pharmacotherapy
2015a; 35:220–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25644979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee H, Unemo M, Kim HJ
et al.
Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea . J Antimicrob Chemoth
2015b;70:2536–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4539094</ArticleId>
            <ArticleId IdType="pubmed">26084303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee WC, Anton BP, Wang S
et al.
The complete methylome of Helicobacter pylori UM032. BMC Genomics
2015c;16:424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4450513</ArticleId>
            <ArticleId IdType="pubmed">26031894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis DA. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
Sex Transm Infect
2015;91:234–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25911525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maravić G, Flögel M. RNA methylation and antibiotic resistance: an overview. Period Biol
2004;106:135–40.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin IM, Ison CA, Aanensen DM
et al.
Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis
2004;189:1497–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15073688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClure R, Nudel K, Massari P
et al.
The gonococcal transcriptome during infection of the lower genital tract in women. PloS One
2015;10:e0133982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526530</ArticleId>
            <ArticleId IdType="pubmed">26244506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metcalf BJ, Chochua S, Gertz RE
et al.
Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect
2016;22:1002–e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27542334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris SR, Moore DF, Hannah PB
et al.
Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak. J Clin Microbiol
2009;47:2944–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2738060</ArticleId>
            <ArticleId IdType="pubmed">19625477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morse SA, Johnson SR, Biddle JW
et al.
High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Ch
1986;30:664–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC176510</ArticleId>
            <ArticleId IdType="pubmed">3099640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray IA, Clark TA, Morgan RD
et al.
The methylomes of six bacteria. Nucleic Acids Res
2012;40:11450–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3526280</ArticleId>
            <ArticleId IdType="pubmed">23034806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair S, Ashton P, Doumith M
et al.
WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanism of resistance to azithromycin in a UK population of non-typhoidal Salmonella. J Antimicrob Chemoth
2016;71:3400–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27585964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa H, Wardell CP, Furuta M
et al.
Cancer whole-genome sequencing: present and future. Oncogene
2015;34: 5943–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25823020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newman L, Rowley J, Vander Hoorn
et al.
Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PloS One
2015;10:e0143304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4672879</ArticleId>
            <ArticleId IdType="pubmed">26646541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng LK, Martin I, Liu G
et al.
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Ch
2002;46:3020–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127397</ArticleId>
            <ArticleId IdType="pubmed">12183262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnishi M, Golparian D, Shimuta K
et al.
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Ch
2011; 55:3538–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3122416</ArticleId>
            <ArticleId IdType="pubmed">21576437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnishi M, Watanabe Y, Ono E
et al.
Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Ch
2010;54:1060–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2826007</ArticleId>
            <ArticleId IdType="pubmed">20028823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olesky M, Hobbs M, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Ch
2002;46:2811–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127413</ArticleId>
            <ArticleId IdType="pubmed">12183233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer HM, Young H, Graham C
et al.
Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex Transm Infect
2008;84:280–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18256103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papp JR, Abrams AJ, Nash E
et al.
Characterization of a cluster of Neisseria gonorrhoeae isolates from Hawaii with azithromycin resistance and decreased in vitro susceptibility to ceftriaxone. Emerg Infect Dis
2017;23, https://wwwnc.cdc.gov/eid/article/23/5/17-0088article (date last accessed,
20 April 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Park ST, Kim J. Trends in next-generation sequencing and a new era for whole genome sequencing. Int Neurourol J
2016;20:S76–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5169091</ArticleId>
            <ArticleId IdType="pubmed">27915479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirone-Davies C, Hoffmann M, Roberts RJ
et al.
Genome-wide methylation patterns in Salmonella enterica subsp. enterica serovars. PloS One
2015;10:e0123639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4393132</ArticleId>
            <ArticleId IdType="pubmed">25860355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powers JG, Weigman VJ, Shu J
et al.
Efficient and accurate whole genome assembly and methylome profiling of E. coli. BMC Genomics
2013;14:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4046830</ArticleId>
            <ArticleId IdType="pubmed">24090403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price J, Claire Gordon N, Crook D
et al.
The usefulness of whole genome sequencing in the management of Staphylococcus aureus infections. Clin Microbiol Infect
2013;19:784–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23331482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Ottawa: Public Health Agency of Canada, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Public Health Agency of Canada. Report on Sexually Transmitted Infections in Canada: 2012. Centre for Communicable Diseases and Infection Control. Ottawa: Public Health Agency of Canada, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Public Health England. Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae: Key Findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP). London: Public Health England, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Remmele CW, Xian Y, Albrecht M
et al.
Transcriptional landscape and essential genes of Neisseria gonorrhoeae. Nucleic Acids Res
2014;42:10579–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4176332</ArticleId>
            <ArticleId IdType="pubmed">25143534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell
2015;58:586–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4494749</ArticleId>
            <ArticleId IdType="pubmed">26000844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seth-Smith HM, Thomson NR. Whole-genome sequencing of bacterial sexually transmitted infections: implications for clinicians. Curr Opin Infect Dis
2013;26:90–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23221768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimuta K, Unemo M, Nakayama SI
et al.
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Ch
2013;57:5225–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3811299</ArticleId>
            <ArticleId IdType="pubmed">23939890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimuta K, Watanabe Y, Nakayama SI
et al.
Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan. BMC Infect Dis
2015;15:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4574456</ArticleId>
            <ArticleId IdType="pubmed">26381611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shultz TR, Tapsall JW, White PA. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC . Antimicrob Agents Ch
2001; 45:734–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC90365</ArticleId>
            <ArticleId IdType="pubmed">11181352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sosa J, Ramirez-Arcos S, Ruben M
et al.
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995–1998. Sex Transm Dis
2003;30:443–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12916137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Starnino S, Stefanelli P, Neisseria gonorrhoeae Italian Study Group, Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemoth
2009;63:1200–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19357159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki S, Horinouchi T, Furusawa C. Prediction of antibiotic resistance by gene expression profiles. Nat Commun
2014;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4351646</ArticleId>
            <ArticleId IdType="pubmed">25517437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swaminathan S, Sundaramurthi JC, Palaniappan AN
et al.
Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis. Tuberculosis
2016;101:31–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27865394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapsall JW. Antimicrobial Resistance in Neisseria gonorrhoeae. Geneva: World Health Organization; 2001. 
WHO document WHO. CDS/CSR/DRS.</Citation>
        </Reference>
        <Reference>
          <Citation>Tapsall JW, Ndowa F, Lewis DA
et al.
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther
2009; 7:821–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19735224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thakur SD, Levett PN, Horsman GB
et al.
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally. Sex Transm Infect
2014;90:297–302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24503900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trembizki E, Wand H, Donovan B
et al.
The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012. Clin Infect Dis
2016;63:1591–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27682063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyson GH, McDermott PF, Li C
et al.
WGS accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemoth
2015;70:2763–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26142410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M. Current and future antimicrobial treatment of gonorrhea-the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis
2015;15:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4546108</ArticleId>
            <ArticleId IdType="pubmed">26293005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Dillon JAR. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev
2011;24:447–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3131056</ArticleId>
            <ArticleId IdType="pubmed">21734242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, del Rio C, Shafer WM. Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century. Microbiol Spectrum
2016;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4920088</ArticleId>
            <ArticleId IdType="pubmed">27337478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev
2014;27:587–613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4135894</ArticleId>
            <ArticleId IdType="pubmed">24982323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Golparian D, Nicholas R
et al.
High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Ch
2012;56:1273–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3294892</ArticleId>
            <ArticleId IdType="pubmed">22155830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Golparian D, Skogen V
et al.
Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Ch
2013;57:1057–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3553714</ArticleId>
            <ArticleId IdType="pubmed">23183436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol
2002;184:5619–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC139619</ArticleId>
            <ArticleId IdType="pubmed">12270819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vidovic S, Caron C, Taheri A
et al.
Using crude whole-genome assemblies of Neisseria gonorrhoeae as a platform for strain analysis: clonal spread of gonorrhea infection in Saskatchewan, Canada. J Clin Microbiol
2014;52:3772–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4187769</ArticleId>
            <ArticleId IdType="pubmed">25056324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet
2009;10:57–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2949280</ArticleId>
            <ArticleId IdType="pubmed">19015660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Workowski KA, Bolan GA. Sexually Transmitted Diseases Treatment Guidelines. MMWR Recomm Rep
2015;64:60–8.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008. Geneva: World Health Organization, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: World Health Organization, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Geneva: World Health Organization, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Wright MS, Suzuki Y, Jones MB
et al.
Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Ch
2015;59:536–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4291396</ArticleId>
            <ArticleId IdType="pubmed">25385117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyres KL, Conway TC, Garg S
et al.
WGS analysis and interpretation in clinical and public health microbiology laboratories: what are the requirements and how do existing tools compare?. Pathogens
2014;3:437–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4243455</ArticleId>
            <ArticleId IdType="pubmed">25437808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yong D, Kim TS, Choi JR
et al.
Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries. J Antimicrob Chemoth
2004;54:451–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15231766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarantonelli L, Borthagaray G, Lee EH
et al.
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Ch
1999;43:2468–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC89502</ArticleId>
            <ArticleId IdType="pubmed">10508026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao S, Tyson GH, Chen Y
et al.
Whole-genome sequencing analysis accurately predicts antimicrobial resistance phenotypes in Campylobacter spp. Appl Environ Microb
2016;82:459–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4711122</ArticleId>
            <ArticleId IdType="pubmed">26519386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Zhong J, Jia X
et al.
Precision methylome characterization of Mycobacterium tuberculosis complex (MTBC) using PacBio single-molecule real-time (SMRT) technology. Nucleic Acids Res
2016;44:730–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4737169</ArticleId>
            <ArticleId IdType="pubmed">26704977</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
